DE69725747D1 - Liposome enthaltend cisplatin - Google Patents

Liposome enthaltend cisplatin

Info

Publication number
DE69725747D1
DE69725747D1 DE69725747T DE69725747T DE69725747D1 DE 69725747 D1 DE69725747 D1 DE 69725747D1 DE 69725747 T DE69725747 T DE 69725747T DE 69725747 T DE69725747 T DE 69725747T DE 69725747 D1 DE69725747 D1 DE 69725747D1
Authority
DE
Germany
Prior art keywords
liposomes
liposome containing
entrapped
compound
containing cisplatin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69725747T
Other languages
English (en)
Other versions
DE69725747T2 (de
Inventor
M Abra
Karen Reis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Sequus Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sequus Pharmaceuticals Inc filed Critical Sequus Pharmaceuticals Inc
Application granted granted Critical
Publication of DE69725747D1 publication Critical patent/DE69725747D1/de
Publication of DE69725747T2 publication Critical patent/DE69725747T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69725747T 1996-08-23 1997-08-19 Liposome enthaltend cisplatin Expired - Fee Related DE69725747T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2435096P 1996-08-23 1996-08-23
US24350P 1996-08-23
PCT/US1997/014541 WO1998007409A1 (en) 1996-08-23 1997-08-19 Liposomes containing a cisplatin compound

Publications (2)

Publication Number Publication Date
DE69725747D1 true DE69725747D1 (de) 2003-11-27
DE69725747T2 DE69725747T2 (de) 2004-07-29

Family

ID=21820133

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69725747T Expired - Fee Related DE69725747T2 (de) 1996-08-23 1997-08-19 Liposome enthaltend cisplatin

Country Status (13)

Country Link
US (2) US5945122A (de)
EP (1) EP0929293B1 (de)
JP (1) JP2001501173A (de)
AT (1) ATE252372T1 (de)
AU (1) AU714992B2 (de)
CA (1) CA2263455C (de)
DE (1) DE69725747T2 (de)
DK (1) DK0929293T3 (de)
ES (1) ES2208946T3 (de)
HK (1) HK1021320A1 (de)
PT (1) PT929293E (de)
TW (1) TW483759B (de)
WO (1) WO1998007409A1 (de)

Families Citing this family (144)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE506164C2 (sv) * 1995-10-09 1997-11-17 Medscand Medical Ab Instrumentarium för behandling av urininkontinens hos kvinnor
US5972379A (en) * 1995-02-14 1999-10-26 Sequus Pharmaceuticals, Inc. Liposome composition and method for administering a quinolone
ES2208946T3 (es) * 1996-08-23 2004-06-16 Sequus Pharmaceuticals, Inc. Liposomas que contienen un compuesto de cisplatino.
FR2759293B1 (fr) * 1997-02-11 1999-04-30 Ethypharm Lab Prod Ethiques Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
DE19724796A1 (de) * 1997-06-06 1998-12-10 Max Delbrueck Centrum Mittel zur Antitumortherapie
NZ511112A (en) 1998-09-16 2003-11-28 Alza Corp Lipsome-entrapped topoisomerase inhibitors
US20050084524A1 (en) * 1998-09-30 2005-04-21 Alza Corporation Method for potentiating activity of a chemotherapeutic drug
US6932759B2 (en) 1999-06-09 2005-08-23 Gene W. Kammerer Surgical instrument and method for treating female urinary incontinence
WO2000074633A2 (en) * 1999-06-09 2000-12-14 Ethicon, Inc. Method and apparatus for adjusting flexible areal polymer implants
US7121997B2 (en) * 1999-06-09 2006-10-17 Ethicon, Inc. Surgical instrument and method for treating female urinary incontinence
US7226407B2 (en) 1999-06-09 2007-06-05 Ethicon, Inc. Surgical instrument and method for treating female urinary incontinence
US6511676B1 (en) 1999-11-05 2003-01-28 Teni Boulikas Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
WO2001041738A2 (en) * 1999-12-10 2001-06-14 Celator Technologies Inc. Lipid carrier compositions with protected surface reactive functions
MXPA02007320A (es) * 2000-01-28 2004-07-30 Alza Corp Liposomas conteniendo un compuesto atrapado en solucion supersaturada.
US7131943B2 (en) * 2000-03-09 2006-11-07 Ethicon, Inc. Surgical instrument and method for treating organ prolapse conditions
DE10019604C2 (de) * 2000-04-20 2002-06-27 Ethicon Gmbh Implantat
JP2001336528A (ja) * 2000-05-25 2001-12-07 Ntn Corp 磁気浮上装置
US7025063B2 (en) * 2000-09-07 2006-04-11 Ams Research Corporation Coated sling material
EP1324758B1 (de) * 2000-10-03 2005-01-12 Debiopharm S.A. Plga/pla-typ mikrokugeln enthaltend eine wasserlösliche verbindung und herstellungsverfahren dafür
JP4623931B2 (ja) * 2000-12-07 2011-02-02 エンセラデュス、ファーマシューティカルズ、ベスローテン、フェンノートシャップ 炎症性疾患の治療用組成物
US6652450B2 (en) 2001-01-23 2003-11-25 American Medical Systems, Inc. Implantable article and method for treating urinary incontinence using means for repositioning the implantable article
US6612977B2 (en) 2001-01-23 2003-09-02 American Medical Systems Inc. Sling delivery system and method of use
US6641525B2 (en) 2001-01-23 2003-11-04 Ams Research Corporation Sling assembly with secure and convenient attachment
DE10107165A1 (de) * 2001-02-15 2002-08-29 Max Planck Gesellschaft Thermolabiles Liposom mit geregelter Freigabetemperatur
WO2002078672A2 (en) * 2001-03-30 2002-10-10 Alza Corporation Liposomal tumor necrosis factor compositions and methods
EP1424898A4 (de) * 2001-08-20 2008-04-02 Transave Inc Behandlung von karzinomen durch inhalation von stabilen platinhaltigen formulierungen
JP2005502653A (ja) * 2001-08-20 2005-01-27 トランセーヴ・インコーポレーテッド 肺ガンの治療方法
PL370867A1 (en) * 2001-09-24 2005-05-30 Tosk, Inc. Reduced toxicity cisplatin formulations and methods for using the same
US7087065B2 (en) * 2001-10-04 2006-08-08 Ethicon, Inc. Mesh for pelvic floor repair
EP1443900B1 (de) * 2001-11-13 2012-05-23 Celator Pharmaceuticals, Inc. Lipidträgerzusammensetzungen mit erhöhter blutstabilität
US6476068B1 (en) 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
CA2477834C (en) 2002-03-01 2008-04-15 Ethicon, Inc. Method and apparatus for treating pelvic organ prolapses in female patients
JP2005530704A (ja) * 2002-03-05 2005-10-13 トランセイブ， インク． 細胞内感染を予防及び治療するための吸入システム
US20030215493A1 (en) * 2002-04-30 2003-11-20 Patel Pravin M. Composition and method for dermatological treatment
US20110142922A1 (en) * 2002-04-30 2011-06-16 Ferndale Ip, Inc. Stabilized composition and method for dermatological treatment
US20090060992A1 (en) * 2002-05-08 2009-03-05 University Of Central Florida Research Foundation, Inc., Preparation of magneto-vesicles with DOPE/DDAB layers
JP3415131B1 (ja) * 2002-06-03 2003-06-09 メビオファーム株式会社 リポソーム製剤
US20040022842A1 (en) * 2002-06-03 2004-02-05 Mebiopharm Co., Ltd. Liposome preparations containing oxaliplatin
US20050152962A1 (en) * 2002-06-12 2005-07-14 Metselaar Josbert M. Composition for treatment of inflammatory disorders
KR20050038011A (ko) * 2002-08-02 2005-04-25 트랜세이브, 인코포레이티드 백금 응집체 및 이의 제조 방법
US9186322B2 (en) 2002-08-02 2015-11-17 Insmed Incorporated Platinum aggregates and process for producing the same
EP1393720A1 (de) * 2002-08-27 2004-03-03 Universiteit Utrecht Vesikel enthaltend Corticosteroide zur Behandlung von Krebs
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
US7718189B2 (en) * 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
ES2686361T3 (es) * 2002-10-29 2018-10-17 Insmed Incorporated Liposomas que comprenden un aminoglucósido para el tratamiento de infecciones pulmonares
WO2004047801A2 (en) * 2002-11-26 2004-06-10 Gilead Sciences, Inc. Method of drug loading in liposomes by gradient
MXPA05006579A (es) * 2002-12-19 2005-12-14 Johnson & Johnson Metodo para tratar el crecimiento de tejido angiogenico.
CA2511464C (en) * 2002-12-31 2011-08-23 Bharat Serums & Vaccines Ltd. Non-pegylated long-circulating liposomes
CA2517352A1 (en) * 2003-02-28 2004-09-16 Alza Corporation Liposome composition for reduction of liposome-induced complement activation
US7968115B2 (en) 2004-03-05 2011-06-28 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of cancer
US20060198882A1 (en) * 2003-03-21 2006-09-07 Yechezkel Barenholz Stable liposomes or micelles comprising a sphinolipid and a peg-lipopolymer
EP1628641A2 (de) * 2003-05-19 2006-03-01 Baxter International Inc. Feste partikel, die ein antikonvulsivum oder ein immunsuppressivum enthalten und die mit einer oder mehreren oberflächen-modifizierenden substanzen beschichtet sind
CA2526278A1 (en) * 2003-05-20 2004-12-02 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising a liposomal platinum complex
WO2005018607A1 (ja) * 2003-08-20 2005-03-03 Ajinomoto Co., Inc. 溶解性を改善した医薬品製剤
CN100471493C (zh) * 2003-12-17 2009-03-25 梅比欧法姆股份有限公司 含有奥沙利铂的脂质体制剂
US8784881B2 (en) * 2004-03-05 2014-07-22 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of diseases
US20080103213A1 (en) * 2004-03-05 2008-05-01 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of neurofibromatosis
US20070065522A1 (en) * 2004-03-18 2007-03-22 Transave, Inc. Administration of high potency platinum compound formulations by inhalation
EP1729786A4 (de) * 2004-03-18 2008-03-26 Transave Inc Verabreichung von cisplatin durch inhalation
US8047982B2 (en) * 2004-05-07 2011-11-01 Ethicon, Inc. Mesh tape with wing-like extensions for treating female urinary incontinence
WO2005112957A1 (en) * 2004-05-21 2005-12-01 Transave, Inc. Treatment of lung diseases and pre-lung disease conditions
JP4850833B2 (ja) * 2004-07-28 2012-01-11 エシコン・インコーポレイテッド 低侵襲性医療インプラントならびにその挿入器具および使用方法
JP2006056807A (ja) * 2004-08-18 2006-03-02 Konica Minolta Medical & Graphic Inc 光線力学療法製剤
JP4715133B2 (ja) * 2004-08-26 2011-07-06 コニカミノルタエムジー株式会社 抗腫瘍リポソーム製剤およびその製造方法
JP2006069929A (ja) * 2004-08-31 2006-03-16 Konica Minolta Medical & Graphic Inc 真菌症治療製剤およびその製造方法
CN101043875B (zh) 2004-09-09 2014-05-07 耶路撒冷希伯来大学伊萨姆研发公司 糖皮质激素和糖皮质激素衍生物的脂质体组合物
US7527588B2 (en) * 2004-09-15 2009-05-05 Ethicon, Inc. System and method for surgical implant placement
KR20070089693A (ko) * 2004-11-08 2007-08-31 트랜세이브, 인코포레이티드 지질-기재 플래티넘 화합물 제형을 복막내 투여하여 암을치료하는 방법
US7481314B2 (en) * 2005-02-02 2009-01-27 Ethicon, Inc. Packaging assembly for surgical mesh implants
JP2006248978A (ja) * 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
US20060283742A1 (en) * 2005-06-16 2006-12-21 Canel Lightning Co. Ltd. Multi-lamp display packaging for lamps with collapsible lampshades
CN1913508B (zh) * 2005-08-08 2010-05-05 华为技术有限公司 基于正交频分复用的信号调制方法及其调制装置
US7855279B2 (en) * 2005-09-27 2010-12-21 Amunix Operating, Inc. Unstructured recombinant polymers and uses thereof
US7846445B2 (en) * 2005-09-27 2010-12-07 Amunix Operating, Inc. Methods for production of unstructured recombinant polymers and uses thereof
AU2006294644A1 (en) * 2005-09-27 2007-04-05 Amunix, Inc. Proteinaceous pharmaceuticals and uses thereof
US20090099031A1 (en) * 2005-09-27 2009-04-16 Stemmer Willem P Genetic package and uses thereof
WO2007056236A2 (en) * 2005-11-08 2007-05-18 Transave, Inc. Methods of treating cancer with lipid-based platinum compound formulations administered intravenously
US9107824B2 (en) * 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
WO2007056263A2 (en) * 2005-11-08 2007-05-18 Transave, Inc. Methods of treating cancer with high potency lipid-based platinum compound formulations administered intravenously
WO2007056264A2 (en) * 2005-11-08 2007-05-18 Transave, Inc. Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
WO2007064658A2 (en) * 2005-11-30 2007-06-07 Transave, Inc. Safe and effective methods of administering therapeutic agents
PL1962805T3 (pl) 2005-12-08 2017-01-31 Insmed Incorporated Kompozycje środków przeciwzapalnych oparte na lipidach do leczenia infekcji płucnych
EP1981525B1 (de) 2005-12-30 2015-01-21 Zensun (Shanghai) Science and Technology Limited Verlängerte freisetzung von neuregulin für verbesserte herzfunktion
JPWO2007089043A1 (ja) * 2006-02-03 2009-06-25 武田薬品工業株式会社 リポソーム製剤
JP5364381B2 (ja) * 2006-12-08 2013-12-11 片山化学工業株式会社 アンミン白金錯体を高濃度で内包するリポソームおよびその製造方法
US8536113B2 (en) * 2006-12-21 2013-09-17 Janssen Biotech, Inc. EGFR binding peptides and uses thereof
US8834920B2 (en) 2006-12-21 2014-09-16 Alza Corporation Liposome composition for targeting egfr receptor
WO2008079976A2 (en) 2006-12-21 2008-07-03 Centocor, Inc. Dimeric high affinity egfr constructs and uses thereof
WO2008137717A1 (en) 2007-05-04 2008-11-13 Transave, Inc. Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
TW200916094A (en) * 2007-06-27 2009-04-16 Poniard Pharmaceuticals Inc Stabilized picoplatin dosage form
KR20100058541A (ko) * 2007-08-15 2010-06-03 아뮤닉스 인코포레이티드 생물학적 활성 폴리펩티드의 특성을 변경하기 위한 조성물 및 방법
US20120003294A1 (en) 2007-08-17 2012-01-05 Celator Pharmaceuticals, Inc. Fixed ratio camptothecens/platinum agents
JP2010540498A (ja) 2007-09-28 2010-12-24 ウニヴェルズィテーツシュピタール バーゼル 癌の治療のための免疫リポソーム
US20090130017A1 (en) * 2007-11-19 2009-05-21 Searete Llc Targeted short-lived drug delivery
TWI468188B (zh) * 2008-01-30 2015-01-11 Univ Tokushima Anti-cancer effect enhancers consisting of oxaliplatin liposomal preparations and anticancer agents comprising the formulation
CA2725535C (en) * 2008-05-23 2016-01-05 The University Of British Columbia Modified drugs for use in liposomal nanoparticles
US20100035853A1 (en) * 2008-08-07 2010-02-11 Hyogo College Of Medicine Method for preventing or treating cisplatin-induced nephrotoxicity
US9322831B2 (en) * 2008-09-23 2016-04-26 The Johns Hopkins University DDX3 as a biomarker for cancer and methods related thereto
US8449573B2 (en) 2008-12-05 2013-05-28 Boston Scientific Scimed, Inc. Insertion device and method for delivery of a mesh carrier
CN116925238A (zh) 2009-02-03 2023-10-24 阿穆尼克斯制药公司 延伸重组多肽和包含该延伸重组多肽的组合物
EP2228059A1 (de) 2009-03-12 2010-09-15 Universitätsspital Basel Chemotherapeutische Zusammensetzung für die Krebsbehandlung
WO2010120336A1 (en) * 2009-04-15 2010-10-21 Poniard Pharmaceuticals, Inc. High bioavailability oral picoplatin anti-cancer therapy
US8968334B2 (en) 2009-04-17 2015-03-03 Boston Scientific Scimed, Inc. Apparatus for delivering and anchoring implantable medical devices
CA2764108A1 (en) 2009-06-08 2010-12-16 Amunix Operating Inc. Glucose-regulating polypeptides and methods of making and using same
EP3278813A1 (de) 2009-06-08 2018-02-07 Amunix Operating Inc. Wachstumshormonpolypeptide sowie verfahren zur herstellung und verwendung davon
EP2440250A1 (de) 2009-06-11 2012-04-18 Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. Gezielt ausgerichtete liposome mit n-haltigen bisphosphonaten und ihre verwendung
CN102741422B (zh) 2009-08-24 2016-06-08 阿穆尼克斯运营公司 凝血因子ⅶ组合物及其制备和使用方法
DK177529B1 (en) * 2009-10-23 2013-09-08 Bio Bedst Aps Liposomes with improved storage stability
CA2778678A1 (en) 2009-10-30 2011-05-05 Cns Therapeutics, Inc. Improved neurturin molecules
US9301750B2 (en) * 2009-11-03 2016-04-05 Boston Scientific Scimed, Inc. Device and method for delivery of mesh-based devices
EP2531175A2 (de) 2010-02-01 2012-12-12 Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. Liposomen mit amphipathischen wirkstoffen und herstellungsverfahren dafür
US9518114B2 (en) 2010-11-12 2016-12-13 Purdue Research Foundation Treating bladder tumor cells using fibronectin attachment protein as a target
EP2508176A1 (de) 2011-04-08 2012-10-10 Lipotarg Gmbh Neues Kombinatonsbehandlung für Krebs
US10085940B2 (en) 2011-07-13 2018-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Liposomes co-encapsulating a bisphosphonate and an amphipathic agent
US20150004219A1 (en) 2012-02-02 2015-01-01 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Stable liposomes for drug delivery
JP6383666B2 (ja) 2012-02-15 2018-08-29 バイオベラティブ セラピューティクス インコーポレイテッド 組換え第ｖｉｉｉ因子タンパク質
JP6256882B2 (ja) 2012-02-15 2018-01-10 アムニクス オペレーティング インコーポレイテッド 第ｖｉｉｉ因子組成物、ならびに組成物の作製方法および用途
JP6402097B2 (ja) 2012-05-21 2018-10-10 インスメッド インコーポレイテッド 肺感染症を処置するためのシステム
WO2013184938A2 (en) 2012-06-08 2013-12-12 Alkermes. Inc. Fusion polypeptides comprising mucin-domain polypeptide linkers
MX2015000813A (es) 2012-07-18 2015-09-07 Onyx Therapeutics Inc Composiciones liposómicas de inhibidores de proteasoma basadas en epoxicetona.
MA37931A1 (fr) * 2012-08-13 2016-07-29 Teni Boulikas Procédés améliorés permettant de traiter un cancer avec une toxicité rénale réduite
JP2015530387A (ja) 2012-09-04 2015-10-15 エライゾン ファーマシューティカルズ， エルエルシー 脂質複合体化シスプラチンによる肺癌の再発防止
US20150246137A1 (en) * 2012-09-27 2015-09-03 The University Of North Carolina At Chapel Hill Lipid coated nanoparticles containing agents having low aqueous and lipid solubilities and methods thereof
ES2743039T3 (es) 2012-11-29 2020-02-18 Insmed Inc Formulaciones de vancomicina estabilizada
US9556214B2 (en) * 2012-12-19 2017-01-31 Placon Therapeutics, Inc. Compounds, compositions, and methods for the treatment of cancers
MX2015012200A (es) * 2013-03-13 2015-11-30 Mallinckrodt Llc Composiciones de oxaliplatino en liposomas para la terapia contra el cancer.
MX2015012199A (es) 2013-03-13 2015-11-30 Mallinckrodt Llc Composiciones de cisplatino liposomal para la terapia contra el cancer.
US10548953B2 (en) 2013-08-14 2020-02-04 Bioverativ Therapeutics Inc. Factor VIII-XTEN fusions and uses thereof
US9987375B2 (en) * 2013-09-23 2018-06-05 Amirhossein Sahebkar Method and composition for treatment of dyslipidemia and other diseases
RU2016141622A (ru) 2014-03-25 2018-04-25 Зэ Гавермент Оф Зэ Юнайтед Стэйтс Оф Америка Эс Репрезентед Бай Зэ Секретари Оф Зэ Арми Нетоксичный адъювантный состав, содержащий композицию содержащей монофосфорил-липид а (mpla) липосомы и сапонин
US10238675B2 (en) 2014-05-15 2019-03-26 Insmed Incorporated Methods for treating pulmonary non-tuberculous mycobacterial infections
US20180071253A1 (en) 2015-03-17 2018-03-15 Lipomedix Pharmaceuticals Ltd. Methods for the treatment of bladder cancer
BR112018002150A2 (pt) 2015-08-03 2018-09-18 Bioverativ Therapeutics Inc proteínas de fusão do fator ix e métodos de fabricação e uso das mesmas
SG10202012205XA (en) 2015-11-06 2021-01-28 Adjuvance Technologies Inc Triterpene saponin analogues
FR3051674B1 (fr) * 2016-05-31 2019-11-08 Universite De Bourgogne Lipoproteines chargees en complexes de platine pour le traitement du cancer
CN109996809A (zh) 2016-11-14 2019-07-09 诺华股份有限公司 与促融合蛋白minion相关的组合物、方法和治疗用途
JP2020536946A (ja) 2017-10-16 2020-12-17 アジュバンス・テクノロジーズ・インコーポレーテッド トリテルペンサポニン類似物
EP3706801A4 (de) * 2017-11-08 2022-04-06 L.E.A.F Holdings Group LLC Platinkomplexe und verwendungen davon
WO2019191627A1 (en) 2018-03-30 2019-10-03 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
CN114163481B (zh) * 2021-12-06 2023-06-23 郑州大学 一种含铂类药物纳米囊泡及其制备方法与应用
WO2023175454A1 (en) 2022-03-14 2023-09-21 Pfizer Inc. Methods for producing an adjuvant

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1162479A (en) * 1980-03-31 1984-02-21 Murray A. Kaplan Pharmaceutical formulations containing cisplatin
US5041581A (en) * 1985-10-18 1991-08-20 The University Of Texas System Board Of Regents Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
WO1991016040A1 (en) * 1990-04-18 1991-10-31 Takeda Chemical Industries, Ltd. Liposome composition
JP3220180B2 (ja) * 1991-05-23 2001-10-22 三菱化学株式会社 薬剤含有タンパク質結合リポソーム
EP0551169A1 (de) * 1992-01-10 1993-07-14 Takeda Chemical Industries, Ltd. Liposomzusammensetzung und Verfahren
ES2208946T3 (es) * 1996-08-23 2004-06-16 Sequus Pharmaceuticals, Inc. Liposomas que contienen un compuesto de cisplatino.

Also Published As

Publication number Publication date
EP0929293A1 (de) 1999-07-21
ATE252372T1 (de) 2003-11-15
JP2001501173A (ja) 2001-01-30
TW483759B (en) 2002-04-21
DE69725747T2 (de) 2004-07-29
AU714992B2 (en) 2000-01-13
DK0929293T3 (da) 2004-02-02
PT929293E (pt) 2004-03-31
WO1998007409A1 (en) 1998-02-26
CA2263455C (en) 2002-10-29
HK1021320A1 (en) 2000-06-09
ES2208946T3 (es) 2004-06-16
CA2263455A1 (en) 1998-02-26
US6126966A (en) 2000-10-03
US5945122A (en) 1999-08-31
EP0929293B1 (de) 2003-10-22
AU3985697A (en) 1998-03-06

Similar Documents

Publication Publication Date Title
ATE252372T1 (de) Liposome enthaltend cisplatin
ATE202942T1 (de) Blutverträglicher beschichteter artikel
BR9914601A (pt) Inibidor de topoisomerase capturado por lipossoma
PT932391E (pt) Composicao lipossomal fusogenica e metodo
EP0265906A3 (de) Wundverband
WO1999051202A3 (en) Quinolone containing liposomes and their use as antibacterial agents
EP1291941A3 (de) Positives aktives Material für Batterie und Verfahren zu seiner Herstellung
AU2547195A (en) Crosslinked hybrid electrolyte film and methods of making and using the same
IE46009L (en) Superficially porous macroparticles
AU4834393A (en) Method of forming air film on submerged surface of submerged part-carrying structure, and film structure on submerged surface
MX9801119A (es) Ebcristalado con revestimiento anti-reflejo.
DE69101639T2 (de) Anwendung von löslichen fluorhaltigen tensiden zur herstellung von aerosol-präparaten mit dosierter abgabe.
AU3629095A (en) Encapsulated active materials and method for preparing the same
AU7481591A (en) Single or multiple layer foil partially composed of starch
EP0352843A3 (de) Lager
EP0805353A3 (de) Immunoreaktion-Agens und Verfahren zu seiner Herstellung
DE69824045D1 (de) Festkörperoxidation eines polymers welche einen oxidierbaren galaktose-typ mit einer alkoholkonfiguration enthalten
FR2780407B1 (fr) Composition silicone reticulable utilisable, notamment pour la realisation de revetement et/ou d'impregnation hydrophobe et/ou oleophobe, a faible energie de surface
ID16653A (id) Komposisi pelapis polimer-polimer flour dan benda yang dilapisi dengan komposisi tersebut.
EP0335361A3 (de) Elektrotauchlackierungszusammensetzung
DE69014890T2 (de) Verfahren zur herstellung von aluminiumnitridpulver beschichtet mit oxiden, oxynitriden oder nitriden von yttrium.
AU2706497A (en) A method for applying paint to a surface
ES2103496T3 (es) Pelicula desprendible y metodo de fabricacion de una pelicula desprendible.
TW328051B (en) Chord wire
AU6208599A (en) Metal-coated plastic part and method for making same

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee